Chemical Structure
GV-58 [1402821-41-3]
AG-MR-C0035
Overview
- SupplierAdipoGen Life Sciences
- Product NameGV-58
- Delivery Days Customer10
- CAS Number1402821-41-3
- CertificationResearch Use Only
- Estimated Purity>97%
- Hazard InformationWarning
- Molecular FormulaC18H26N6OS
- Molecular Weight374.5
- Scientific DescriptionChemical. Formula: C18H26N6OS. MW: 374.5. Selective N- and P/Q-type Ca2+-channel agonist. These Ca2+-channels regulate transmitter release in synapses. Potential lead compound for a variety of disorders that result in neuromuscular weakness. - Selective N- and P/Q-type Ca2+-channel agonist. These Ca2+-channels regulate transmitter release in synapses. Potential lead compound for a variety of disorders that result in neuromuscular weakness.
- SMILESCCCN1C=NC2=C(NCC3=CC=C(C)S3)N=C(N[C@H](CC)CO)N=C12
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC51202000
References
- Synthesis and biological evaluation of a selective N- and P/Q-type Calcium channel agonist: M. Liang, et al.; ACS Med. Chem. Lett. 3, 985 (2012)
- New calcium channel agonists as potential therapeutics in Lambert-Eaton myasthenic syndrome and other neuromuscular diseases: T.B. Tarr, et al.; Ann. N. Y. Acad. Sci. 1275, 85 (2012)
- Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndrome: T.B. Tarr, et al.; J. Neurosci. 33, 10559 (2013)